Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies-Reference-Cited by-同舟云学术

Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies

Published:2019-02-07 Issue:6 Volume:58 Page:727-746
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Miller Neil A.^ORCID,Reddy Micaela B.,Heikkinen Aki T.,Lukacova Viera,Parrott Neil

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40262-019-00741-9.pdf

Reference92 articles.

1. Poggesi I, Snoeys J, Van Peer A. The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement. Expert Opin Drug Metab Toxicol. 2014;10(5):631–5.

2. Agoram B, Woltosz WS, Bolger MB. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev. 2001;50(Suppl. 1):S41–67.

3. Teorell T. Kinetics of distribution of substances administered to the body. I. The extravascular modes of administration. Arch Int Pharmacodyn Ther. 1937;57:205–25.

4. Teorell T. Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration. Arch Int Pharmacodyn Ther. 1937;57:226–40.

5. Rowland M, Peck C, Tucker G. Physiologically-based pharmacokinetics in drug development and regulatory science. Annu Rev Pharmacol Toxicol. 2011;51:45–73.

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I clinical trial of NH130 and the prediction of its pharmacokinetics using physiologically based pharmacokinetic modeling;Frontiers in Pharmacology;2024-09-12

2. Physiologically based pharmacokinetic models for systemic disposition of protein therapeutics in rabbits;Frontiers in Pharmacology;2024-08-28

3. Investigating pharmacokinetic profiles of Centella asiatica using machine learning and PBPK modelling;Journal of Biopharmaceutical Statistics;2024-06-11

4. Development and application of the physiologically-based toxicokinetic (PBTK) model for ochratoxin A (OTA) in rats and humans;Ecotoxicology and Environmental Safety;2024-05

5. Development of Mechanistic In Vitro–In Vivo Extrapolation to Support Bioequivalence Assessment of Long-Acting Injectables;Pharmaceutics;2024-04-19